To access this element change to forms mode OFF
Grant Award View - GA58863
Development of a novel point-of-care Plasmodium vivax dot-matrix...
GA ID:
GA58863
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
30-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$1,076,089.59
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Development of a novel point-of-care Plasmodium vivax dot-matrix antibody test to accelerate malaria elimination
Purpose:
To efficiently eliminate P. vivax (Pv), malaria control programs needs tools to detect areas with ongoing transmission and to identify and treat people with dormant Pv liver infection. To assist with these tasks, we are developing a novel cost-efficient and field-deployable diagnostic test that recognises specific patterns in a person’s immune responses to malaria. This test will expand the capacities of current rapid-diagnostic tests to detect not only current but also recent past infections.
GO ID:
GO Title:
NHMRC Development Grants 2019 for funding in 2020
Internal Reference ID:
GNT1171795
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, FRANCE, JAPAN, UNITED KINGDOM